Navigation Links
Cepheid Reports Fourth Quarter And Full Year 2012 Results
Date:1/24/2013

141%Other

1.50.890%6.24.538%Total International29.323.326%102.572.641%Total Product Sales$  89.7$  76.917%$  321.5$  265.521%


  • During the fourth quarter of 2012, Cepheid placed a total of 153 GeneXpert systems in its commercial Clinical business.  Additionally, the Company placed a total of 68 GeneXpert systems as part of its High Burden Developing Country (HBDC) program.  For the year ended December 31, 2012, Cepheid placed a total of 523 GeneXpert systems in its commercial Clinical business and an additional 506 GeneXpert systems as part of its HBDC program.  As of December 31, 2012, a cumulative total of 3,835 GeneXpert systems have been placed worldwide.
  • Cash and cash equivalents were $95.8 million as of December 31, 2012.
  • DSO was 43 days.
  • Business OutlookFor the fiscal year ending December 31, 2013, the Company expects:

  • Total revenue to be in the range of $375 to $385 million;
  • Net income to range from a net loss of $(0.05) to net income of $0.01 per share; 
  • Non-GAAP net income in the range of $0.41 to $0.46 per share. 
  • Expected non-GAAP net income excludes approximately $29 million related to stock compensation expense and approximately $4 million related to the amortization of acquired intangibles.  The fully diluted share count for the year is expected to be approximately 72 million, except in the event of a GAAP loss where the share count would be approximately 67 million shares.

    The following table reconciles net income (loss) per share to the non-GAAP net income per share range:Guidance Range for YearEnding December 31, 2013Low HighNet Income (Loss) Per Share$ (0.05)$  0.01Stock Compensation Expense0.400.39Amortization of Purchased Intangible Assets0.060.06Non-GAAP Measure of Net Income Per Share$   0.41$  0.46Accessing Cepheid's Fourth Quarter and Full Year 2012 Results Conference CallThe Com
    '/>"/>

    SOURCE Cepheid
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Cepheid to Webcast Upcoming Financial Presentations
    2. Cepheid Announces Executive Vice President Emerging Markets
    3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
    8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
    10. Luminex Corporation Reports First Quarter 2012 Results
    11. Hospira Reports First-Quarter 2012 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/2/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Emerging Technologies, Competitive Landscape" report to ... in Clinical Chemistry and Immunodiagnostics: Global Challenges, ... seven-country strategic analysis of major business opportunities ...
    (Date:7/2/2015)... 2. Juli 2015 BGI gab heute ... Hongkong vom American College of Pathologists (CAP) ... das erste klinische Next-Generation-Sequencing Labor, das in ... erhält und somit die höchsten Standards an ... US FDA - 21 CFR Part 11 ...
    (Date:7/2/2015)... 2015  The Commission for Certification in Geriatric ... organization that represents pharmacists in acute and ambulatory ... education for recertification of Certified Geriatric Pharmacists.  ASHP ... for this purpose.  ASHP will join the American ... the CCGP Professional Development Program. ...
    Breaking Medicine Technology:New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2Commission for Certification in Geriatric Pharmacy Adds ASHP as Professional Development Program Provider 2
    ... Iceland, Oct. 9 deCODE genetics,(Nasdaq: DCGN ... patients for its,Phase IIa clinical trial for DG051, ... the prevention of heart attack. In Phase ... the production of leukotriene B4 (LTB4) in a ...
    ... Calif., Oct. 8 Oculus Innovative,Sciences, Inc. (Nasdaq: ... at the 4th Annual BIO InvestorForum Conference to be ... Francisco. The company,s,president and chief executive officer, Hoji Alimi, ... clinical programs and the most recent,quarter on Thursday, October ...
    Cached Medicine Technology:deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack 2deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack 3Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference 2
    (Date:7/4/2015)... IRVINE, California (PRWEB) , ... July 04, 2015 ... ... has earned the solar industry’s leading recognition of technical sales expertise from the ... Certified PV Technical Sales ProfessionalTM. NABCEP is the most highly respected and well ...
    (Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US cancer centers ... minimal asbestos exposure. Click here to read the complete story , just posted ... Center, Cedars Sinai Medical Center, and New York University exposed mice with a mutation ...
    (Date:7/3/2015)... CT (PRWEB) , ... July 03, 2015 , ... Smoothies ... home is a good blender and easily accessible, quality ingredients. Aurora Natural is proud ... smoothie for an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora ...
    (Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The ... he says will reveal biblical truth and expose popular lies regarding proper relationships according ... Don’t Have Sex”, immediately goes into the core of the subject by explaining why ...
    (Date:7/2/2015)... ... 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of ... located in the Lone Star State. The premium frozen yogurt chain was listed as ... store, which opened July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy ...
    Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
    ... 'wonder drug' after it was found to halve the risk of ... that the drug can also serve as a potential cure //for ... ,In this particular study, which tracked 5,000 patients in 39 countries, ... as compared to 127 cases in patients who were on Herceptin ...
    ... with the promotion and co-coordination of research in various ... the country and encourage young minds to work, //it ... to Scientists. ,This was stated by health minister ... K Kasturirangan, who headed the performance appraisal board constituted ...
    ... Kyoto University have found that daily gargling with povidione-iodine reduced ... study have been published in the American Journal of Preventive ... volunteers between the age group of 18 to 65. , ... first group gargled water with povidone-iodine, the second group gargled ...
    ... for small renal cell carcinoma (RCC) tumors; however, it ... preoperatively. // ,Although no specific tumor markers have ... a variable predictor of lymph node and distant metastasis ... to determine the nuclear grade of RCC without removing ...
    ... Demicheli an Italian epidemiologist as done a systematic review of ... (MMR) vaccine.// The study is focused to find out the ... it is believed that use of MMR vaccine shots in ... millions of children around the world and concluded that MMR ...
    ... A 60 mg low-dose version of the prescription weight-loss ... was found to be safe, effective and tolerable in ... the 2005 Annual Meeting of NAASO, The Obesity Society ... compared orlistat 60 mg plus diet to placebo plus ...
    Cached Medicine News:Health News:Daily Gargling May Prevent Common Colds 2Health News:A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma 2Health News:MMR Vaccination not linked to Autism 2Health News:Weight-Loss Medication Evaluated By Nutrition Expert 2
    The complete performance package. Precision handling. Stable platform for device delivery. Enhanced backup support. Unique braid technology. Improved curve retention. Smooth PTFE liner....
    The soft tip sheath design for smooth delivery and retrieval of Constellation advanced mapping basket catheters....
    Fast-Cath, Maximum, Maximum Xtra, and Maximum ACT introducers represent the largest line of standard and specialty hemostasis introducers in the world....
    A steerable diagnostic catheter with optimal maneuverability...
    Medicine Products: